Capecitabine Monotherapy as Palliative Treatment for Patients with Recurrent/Metastatic Nasopharyngeal Cancer.
Bader AlshamsanAhmed Mostafa GadMaaz Kamal AlataMashari AlzahraniTusneem ElhassanJean Paul AtallahPublished in: Journal of oncology (2022)
Capecitabine monotherapy is effective and well-tolerated as a palliative treatment for R/M NPC. Despite the lower incidence of HFS in our patients, it remained a favorable prognostic factor for objective response and progression-free survival.